Drugplain

NDC 70710-1805-6

ZITUVIMET XR 1000 mg/1

sitagliptin and metformin hydrochloride · TABLET, FILM COATED, EXTENDED RELEASE

No Recall History

Zituvimet XR is a prescription tablet that combines two diabetes medications—sitagliptin (a DPP-4 inhibitor) and metformin—to help control blood sugar levels in patients with type 2 diabetes. This extended-release formulation is taken by mouth once daily.

Key Facts

Brand Name
ZITUVIMET XR
Generic Name
sitagliptin and metformin hydrochloride
NDC Code (Package)
70710-1805-6
NDC Code (Product)
70710-1805
Manufacturer
Zydus Pharmaceuticals USA Inc.
Strength
1000 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
NDA216778
Drug Class
Dipeptidyl Peptidase 4 Inhibitor [EPC]
Marketing Start
10/31/2024

Recall History

No Recall History

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.